Abstract Number: 92 • 2013 ACR/ARHP Annual Meeting
Kidney Function and Alcohol Intake and The Risk Of Incident Gout In a Population-Based Cohort Of Adults: Atherosclerosis Risk In Communities Study
Background/Purpose: Reduced kidney function is associated with higher urate levels as well as an increased risk of gout. Additionally, alcohol intake is known to increase…Abstract Number: 2586 • 2012 ACR/ARHP Annual Meeting
Tendon and Ligament Involvement in Gout: A Dual Energy Computed Tomography Study
Background/Purpose: The involvement of bone and joints is widely recognized in gout. However, soft tissue involvement is less well defined. Dual energy computed tomography (DECT)…Abstract Number: 2585 • 2012 ACR/ARHP Annual Meeting
Magnetic Resonance Imaging Versus Dual Energy Computed Tomography for Detection of Joint Pathology in Gout
Background/Purpose: Magnetic resonance imaging (MRI) captures joint inflammation and damage in gouty arthropathy and can also reveal tophi. We have investigated reader reliability for scoring…Abstract Number: 2461 • 2012 ACR/ARHP Annual Meeting
Cost-Effectiveness of Systemic Therapies for Acute Gouty Arthritis
Background/Purpose: Rising prevalence has led to increased demand for newer and potentially costly treatments for acute gouty arthritis, but few studies comparing effectiveness and costs…Abstract Number: 2412 • 2012 ACR/ARHP Annual Meeting
Valdiation of a Diagnosis of Gout in the Epiccare Electronic Medical Records
Background/Purpose: Electronic Medical Records (EMR) offer great opportunities for pharmacoepidemiologic, health outcome and health services research. However, the critical limiting factor in the widespread use of…Abstract Number: 2041 • 2012 ACR/ARHP Annual Meeting
Improving Access and Patient Education in Rheumatology: the Gout Shared Medical Appointment; a Quality Improvement Initiative
Background/Purpose: Patients experience long waits for consultations in Rheumatology at Dartmouth-Hitchcock Medical Center (DHMC). The cause of this is multi-factorial, including provider referral patterns, patient preferences,…Abstract Number: 2043 • 2012 ACR/ARHP Annual Meeting
Documentation of Improvement Over 2 Months in Osteoarthritis, Systemic Lupus Erythematosus, Spondyloarthropathy and Gout Similarly to Rheumatoid Arthritis According to Function, Pain, Patient Global Estimate and RAPID3 On a Multidimensional Health Assessment Questionnaire (MDHAQ)
Background/Purpose: The health assessment questionnaire (HAQ) and multidimensional HAQ (MDHAQ) were developed initially to assess patients with rheumatoid arthritis (RA). The most feasible method to…Abstract Number: 2045 • 2012 ACR/ARHP Annual Meeting
Treatment Patterns and Monitoring of Serum Uric Acid Levels in a Large Cohort of Gout Patients in the United States: Is There Room for Improvement?
Background/Purpose: Currently, there are no guidelines in the United States on monitoring serum uric acid (sUA) levels in gout and gout treatment patterns. However, there…Abstract Number: 2037 • 2012 ACR/ARHP Annual Meeting
Poor Quality of Gout Care Is Strongly Associated with Higher Gout-Related Health Care Utilization
Background/Purpose: Proponents of improving quality of gout care have suggested various gout quality indicators, but no study to date has shown the link between…Abstract Number: 1901 • 2012 ACR/ARHP Annual Meeting
Chronic Gout. Improvement According to Outcome Meaures in Rheumatology Domains in Daily Clinical Practice
Background/Purpose: OMERACT has proposed domains to evaluate the effect of treatment in patients with acute and chronic gout. Their frequency, time to improve and percentage…Abstract Number: 1902 • 2012 ACR/ARHP Annual Meeting
What Factors Are Associated with Target Serum Urate Concentrations in Patients with Gout?
Background/Purpose: Long term serum urate (SU) lowering to a target ofAbstract Number: 1903 • 2012 ACR/ARHP Annual Meeting
Oxidation of Urate to Allantoin by Myeloperoxidase in Gout
Background/Purpose : Hyperuricaemia is critical for the development of gout and may play a pivotal role in the pathophysiology of hypertension, metabolic syndrome, and cardiovascular…Abstract Number: 1904 • 2012 ACR/ARHP Annual Meeting
Patterns of Gout Treatment and Related Outcomes in US Community Rheumatology Practices: the Relation Between Gout Flares, Time in Treatment, Serum Uric Acid Level and Urate Lowering Therapy
Background/Purpose: Study patterns of gout treatment and related outcomes in US community rheumatology practices, specifically the relation between likelihood and severity of gout flares, time…Abstract Number: 1906 • 2012 ACR/ARHP Annual Meeting
Changes in Gout patient´s Clinical Profile in the Last Two Decades
Background/Purpose: to assess whether changes in the clinical profile of gout are observed in a large cohort of gout patients over the last 20 years.…Abstract Number: 1907 • 2012 ACR/ARHP Annual Meeting
Pharmacological Management of Gout in Italy in the Years 2005-2009: A Nationwide, Population-Based Study
Background/Purpose: Despite the increasing interest on gout, only few nationwide drug utilization studies have been conducted on this topic. The aim of this study…
Simple Search Results
Didn't find what you were looking for? Try the Advanced Search »
Didn't find what you were looking for? Try the Advanced Search »